Industry payments to physicians linked to use of some non-recommended and low value drugs among cancer patients
Findings raise quality of care concerns about this common practice, say researchers Patients with cancer whose oncologist receives payments from industry appear more likely to receive some non-recommended and low value treatments, finds a US study published by The BMJ today. This finding raises potential concerns about quality of care, and the ...

